Trulieve Cannabis (CSE: TRUL) has again seen a change in the role of chief financial officer. The company this morning announced that Wes Getman, whom was appointed to the role on January 1, 2024, has left the company effective March 5, 2025. He lasted roughly 14 months in the role.
Little was said about Getman’s departure, aside from his resignation not being based on any disagreement with the company on accounting principles, practices, or financial disclosures. CEO Kim Rivers thanked him for his efforts, highlight his role in instituting controls related to Sarbanes Oxley requirements last year.
Trulieve VP of Finance Ryan Blust will again serve as interim chief financial officer for the company, a role he filled on an interim basis prior to Getman’s appointment in late 2023. Blust has been with Trulieve since 2018, serving as interim CFO in 2023 following the departure of Alex D’Amico as CEO, and again in 2024, following the departure of Tim Mullany from the role after roughly 11 months.
Trulieve Cannabis last traded at $5.91 on the CSE.
Information for this briefing was found via the sources mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
